Related Experiment Video
Updated: Jul 26, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Protease Inhibitors Therapy for AIDS Patients
1Division of Clinical Pharmacology, University of Alabama at Birmingham School of Medicine; Birmingham, Alabama, USA.
Summary
Protease inhibitors significantly improve HIV treatment outcomes. Combining protease inhibitors with other antiretroviral agents increases CD4+ counts, reduces viral load, and lowers mortality rates in patients.
Area of Science:
- Infectious Diseases
- Virology
- Pharmacology
Background:
- HIV infection remains a significant global health challenge.
- Protease inhibitors represent a key class of antiretroviral drugs.
- Previous treatments for HIV have shown limitations in managing viral load and clinical progression.
Purpose of the Study:
- To evaluate the clinical impact of protease inhibitors in HIV treatment.
- To assess the efficacy of protease inhibitor-based regimens in both previously treated and untreated patients.
- To explore different combination strategies involving protease inhibitors.
Main Methods:
- Retrospective analysis of clinical data from HIV-infected patients.
- Inclusion of patients receiving protease inhibitors as part of their antiretroviral therapy.
- Evaluation of treatment outcomes including CD4+ cell counts, plasma viral burden, and clinical events.
Main Results:
- Protease inhibitors significantly increase CD4+ cell counts in HIV patients.
- Combination therapy including protease inhibitors leads to substantial decreases in plasma viral burden.
- Regimens with protease inhibitors result in reduced rates of new clinical events and mortality.
- Pilot studies show impressive efficacy and tolerance for various protease inhibitor combinations.
Conclusions:
- Protease inhibitors have a major clinical impact on HIV treatment.
- Combination antiretroviral therapy including protease inhibitors is effective in managing HIV infection.
- Further research into novel protease inhibitor combinations is warranted.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...